Compare

Vaso Corp vs Ceribell, Inc. vs Outset Medical, Inc. vs Iridex Corp

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearVaso Corp
VASO
Ceribell, Inc.
CBLL
Outset Medical, Inc.
OM
Iridex Corp
IRIX
Year ended2025-12-312025-12-312025-12-312026-01-03
Revenue$89.10M$89.06M$119.48M$52.67M
Revenue growth (YoY)+2.7%+36.1%+5.1%+8.2%
Gross margin61.4%87.9%39.1%36.5%
Operating margin-3.2%-65.6%-55.8%-4.9%
Net margin1.8%-60.0%-68.3%-8.4%
Net income$1.57M-$53.41M-$81.65M-$4.44M
EPS (Diluted)$0.01-$1.46-$5.37-$0.26
Operating cash flow$9.27M-$40.81M-$46.33M-$2.12M
Free cash flown/a-$41.58M-$47.12M-$2.26M
Cash & equivalents$35.05M$40.48M$35.01M$6.03M
Total assets$88.35M$195.80M$264.50M$29.15M
Total liabilitiesn/a$40.47M$137.54M$24.23M
Shareholders' equity$29.43M$155.34M$126.95M$4.92M
Return on year-end equity5.3%-34.4%-64.3%-90.1%
Shares outstanding175.95M37.49M18.17M17.31M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearVaso CorpCeribell, Inc.Outset Medical, Inc.Iridex Corp
Latest$89.10M
Ended 2025-12-31
$89.06M
Ended 2025-12-31
$119.48M
Ended 2025-12-31
$52.67M
Ended 2026-01-03
1 year earlier$86.77M
Ended 2024-12-31
$65.44M
Ended 2024-12-31
$113.69M
Ended 2024-12-31
$48.67M
Ended 2024-12-28
2 years earlier$81.02M
Ended 2023-12-31
$45.23M
Ended 2023-12-31
$130.38M
Ended 2023-12-31
$51.87M
Ended 2023-12-30
3 years earlier$79.29M
Ended 2022-12-31
n/a$115.38M
Ended 2022-12-31
$56.97M
Ended 2022-12-31
4 years earlier$75.58M
Ended 2021-12-31
n/a$102.60M
Ended 2021-12-31
$53.90M
Ended 2022-01-01